EPO and non-small cell lung carcinoma: Suwinski et al. measured six serum proteins in NSCLC patients treated with curative or palliative thoracic radiotherapy, and demonstrated potential utilities of osteopontin (OPN), vascular endothelial growth factor (VEGF), and erythropoietin (EPO) as prognostic factors (7).